| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8771953 | The Journal of Urology | 2017 | 27 Pages |
Abstract
Intraprostatic injections of 2-hydroxyflutamide depot formulations showed antitumor effects, and proved to be safe and tolerable. However, for better anticancer effects higher doses and better dose distribution are suggested.
Keywords
CIT2-HydroxyflutamideMRSIMR spectroscopic imagingdelayed-action preparationsDWISNRMRST2wPSAADCPCAT2-weightedAndrogen antagonistsProstate specific antigenMRIChoMagnetic resonancediffusion-weighted imageMR ImagingProstate volume2-dimensionalProstate cancerCalcium sulfateCitrateapparent diffusion coefficientMR spectroscopyProstatic neoplasmsSignal-to-noise ratioprostate-specific antigenPolyaminecreatineCholine
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Teuvo L. Tammela, Michael Häggman, Sam Ladjevardi, Kimmo Taari, Taina Isotalo, Hans Lennernäs, Jan Weis, Catrin von Below, Cecilia Wassberg, Bo Lennernäs, Anna Tolf, Niklas Axén, Carl-Gustaf Gölander, HÃ¥kan Ahlström,